RxDoctor Payments Data

Ellen McLimore, APRN

Nurse Practitioner · Owensboro, KYNPI 1376853473

Payments from drug & device makers

$5,821in general payments, 2019–2025

Across 386 payments — averaging $15.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Novartis$640
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$604
  • E.r. Squibb & Sons, L.L.C.$600
  • Amgen$586
  • Pfizer$573
  • plus $2K from 16 others

What the payments were for

  • Food & beverage$5,72298%
  • Education$992%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,821 in reported general payments places this provider in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$5,000
Medicare patients
90
Services billed
145

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban400$358,154
XareltoRivaroxaban66$60,543
EntrestoSacubitril/Valsartan67$54,945
BrilintaTicagrelor94$51,384
JardianceEmpagliflozin40$39,192
FarxigaDapagliflozin Propanediol36$23,303
Repatha SureclickEvolocumab34$19,468
Prasugrel Hcl60$5,290
Metoprolol Succinate486$4,360
Rosuvastatin Calcium196$2,615
Ranolazine ErRanolazine40$2,360
ClopidogrelClopidogrel Bisulfate337$2,233
Atorvastatin Calcium354$1,666
Isosorbide Mononitrate ErIsosorbide Mononitrate229$1,363
Losartan Potassium224$1,326

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$573$358,154400 claims
AstraZenecaBrilinta, Farxiga$383$74,687130 claims
Johnson & JohnsonXarelto$1,025$60,54366 claims
NovartisEntresto$640$54,94567 claims
Boehringer IngelheimJardiance$366$39,19240 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Owensboro

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →